The second limitation of the current study is that we could not perform correlation analyses between the transcriptome of each WHO severity level with clinical inflammatory biomarkers (e.g., CRP, procalcitonin, ferritin, neutrophil/lymphocyte ratio, and lymphopenia, etc.)or clinical severity scores (e.g., APACHE II or SOFA scores). This evidence concerns the gene CRP and lymphopenia.